First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

It could be the first long-acting antibody combination to receive an emergency authorization in the U.S. for COVID-19 prevention.

6
Upvote
Save

Comments

Write a comment

*